伊利诺伊州法案试图通过阻止对制造商发放药品的限制来保护340B毒品方案准入。 Illinois bill seeks to protect 340B drug program access by blocking manufacturer dispensing restrictions.

伊利诺伊州的一项法案,HB 2371,正在等待众议院投票,以根据联邦340B方案保护获得折扣药品的机会,该方案允许安全网诊所和医院以低价购买药品。 A bill in Illinois, HB 2371, is awaiting a vote in the House to protect access to discounted drugs under the federal 340B program, which allows safety-net clinics and hospitals to purchase medications at reduced prices. 立法将禁止毒品制造者限制340B药品的发放地点,确保供应者可以使用最能为其病人服务的药房。 The legislation would prohibit drugmakers from restricting where 340B drugs can be dispensed, ensuring providers can use pharmacies that best serve their patients. 倡导者警告说,目前的制造商限制妨碍了对低收入和无保险个人的护理,而反对者则认为需要更广泛的联邦改革。 Advocates warn that current manufacturer restrictions hinder care for low-income and uninsured individuals, while opponents argue broader federal reforms are needed. 该法案得到保健团体的支持,不需要国家资助,其目的是防止患者获得基本药品的机会中断。 The bill, supported by health care groups and not requiring state funding, aims to prevent disruptions in patient access to essential medicines.